PhysEmp :: Medicine :: Medical Specialties :: Gastroenterology :: Images

All Gastroenterology Jobs

Permanent Gastroenterology Job in Outside Boston- smaller practice Massachusetts with CompHealth Inc
Job 918707 2009 fellows welcome B/C or B/E Gastroenterology ERCP, EUS a plus Shared call 1:3 Easy access to Boston or Hartford Great place to raise a family Support of Established Hospitalists Excellent
Permanent Gastroenterology Job in Gastroenterologist need in Massachusetts Massachusetts with CompHealth Inc
Job 918498 Excellent Gastro opportunity located within a short drive to Boston Join two other Gastroenterologists in a family Friendly service area The Local Hospital is assisting in this Gastroenterology
Permanent Gastroenterology Job in Pacific Northwest seeks GI Oregon with CompHealth Inc
Job 918499 Choose between partnership or employed Oregon license B/C or B/E Gastroenterology Choose between joining a group or solo Inherit a waiting patient base Great place to raise a family Generous

Journal of Clinical Gastroenterology - Current Table Of Contents

The Lactulose Breath Test (LBT): Modified, But Still a Lot of Hot Air?
Page: 1067DOI: 10.1097/MCG.0b013e31818474edAuthors: Lieb, John G. MD; Draganov, Peter V. MD
Gastroenterologists' Patient Instructions for Oral Sodium Phosphate Solution for Colonoscopy Preparation: A Survey Among Gastroenterologists in the State of Indiana.
Page: 1070DOI: 10.1097/MCG.0b013e3180f62b25Authors: Gagovic, Veronika MD; Rex, Douglas K. MD
Prevalence and Clinical Characteristics of Barrett's Esophagus in a Chinese General Population.
Page: 1074DOI: 10.1097/MCG.0b013e31809e7126Authors: Tseng, Ping-Huei MD *; Lee, Yi-Chia MD + ++; Chiu, Han-Mo MD ++; Huang, Shih-Pei MD ++; Liao, Wei-Chih MD ++; Chen, Chien-Chuan MD ++; Wang, Hsiu-Po MD [S]; Wu, Ming-Shiang MD, PhD ++; Lin, Jaw-Town MD, PhD ++

FeedNavigator - Journals - Gastroenterology

Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200

Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck!
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200

A simple index on the day of admission which predicts outcome in acute pancreatitis
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200

Doing our best: surgery for rectal cancer
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200

Somatisation in functional dyspepsia: integrating gastric physiology with psychological state
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200

Hepatosplenic T cell lymphoma in inflammatory bowel disease
Gut / Terkko Thu, 20 Nov 2008 19:56:38 +0200


PubMed: 1542-3565

Scirrhous Hepatocellular Carcinoma: Unique Computed Tomography Findings.
Yachida S, Wakabayashi H, Suzuki Y Related Articles Scirrhous Hepatocellular Carcinoma: Unique Computed Tomography Findings. Clin Gastroenterol Hepatol. 2008 Nov 11; Authors: Yachida S, Wakabayashi H, Suzuki Y PMID: 19008158 [PubMed - as supplied by publisher]

Current Opinion in Gastroenterology - Current Table Of Contents

Editorial introductions.
Page: viiiDOI: 10.1097/MOG.0b013e328316c184
Stomach and duodenum.
Page: 657DOI: 10.1097/MOG.0b013e328314b6a1Authors: Schubert, Mitchell L
Gastric secretion.
Page: 659DOI: 10.1097/MOG.0b013e328311a65fAuthors: Schubert, Mitchell L

European Journal of Gastroenterology & Hepatology - Current Table Of Contents

Oesophageal bolus transit and clearance by secondary peristalsis in normal individuals.
Page: 1129DOI: 10.1097/MEG.0b013e328303bff1Authors: Chen, Chien-Lin a b; Szczesniak, Michal M. a; Cook, Ian J. a
Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease.
Page: 1136DOI: 10.1097/MEG.0b013e32830aba6dAuthors: Brillantino, Antonio; Monaco, Luigi; Schettino, Michele; Torelli, Francesco; Izzo, Giuseppe; Cosenza, Angelo; Marano, Luigi; Di Martino, Natale
Helicobacter pylori infection upregulates interleukin-18 production from gastric epithelial cells.
Page: 1144DOI: 10.1097/MEG.0b013e32830edb15Authors: Shimada, Masaaki a b; Ando, Takafumi a; Peek, Richard M. d; Watanabe, Osamu a; Ishiguro, Kazuhiro a; Maeda, Osamu a; Ishikawa, Daisuke a; Hasegawa, Motofusa a; Ina, Kenji c; Ohmiya, Naoki a; Niwa, Yasumasa a; Goto, Hidemi a

Evidence-Based Gastroenterology - Current Table Of Contents

Letter From the Editor.
Page: 59DOI: 10.1097/EBG.0b013e31818e1d57Authors: Eisen, Glenn MD, MPH
RECOMBINANT FACTOR VIIA-IS IT SAFE OR EFFECTIVE FOR VARICEAL BLEEDING IN CIRRHOSIS?
Page: 60DOI: 10.1097/EBG.0b013e31818d66e0Authors: Shah, Neeral MD; Caldwell, Stephen MD
SHOULD WE USE ENDOSCOPIC OR BETA-BLOCKER THERAPY FOR PREVENTION OF FIRST VARICEAL HEMORRHAGE?
Page: 62DOI: 10.1097/EBG.0b013e31818d40efAuthors: Zaman, Atif MD, MPH

Nature Clinical Practice Gastroenterology & Hepatology

Conflicts
Stephen B Hanauer Conflicts Nature Clinical Practice Gastroenterology & Hepatology 5, 589 (2008). doi:10.1038/ncpgasthep1286 Author: Stephen B Hanauer
Risks associated with MRSA and VRE colonization of a liver transplant population
Risks associated with MRSA and VRE colonization of a liver transplant population Nature Clinical Practice Gastroenterology & Hepatology 5, 590 (2008). doi:10.1038/ncpgasthep1265
Liver transplantation: treating recurrent hepatitis C after steroid-free immunosuppression
Liver transplantation: treating recurrent hepatitis C after steroid-free immunosuppression Nature Clinical Practice Gastroenterology & Hepatology 5, 590 (2008). doi:10.1038/ncpgasthep1266

Inflammatory Bowel Diseases

Assessing the activity of perianal crohn's disease: Comparison of clinical indices and computer-assisted anal ultrasound
Alessandra Losco, Chiara Viganò, Dario Conte, Bruno Mario Cesana, Guido Basilisco Thu, 20 Nov 2008 10:14:00 -0000
Background: Assessing perianal disease activity is important for the treatment and prognosis of Crohn's disease (CD) patients, but the diagnostic accuracy of the activity indices has not yet been established. The aim of this study was to determine the accuracy and agreement of the Fistula Drainage Assessment (FDA), Perianal Disease Activity Index (PDAI), and computer-assisted anal ultrasound imaging (AUS).Methods: Sixty-two consecutive patients with CD and perianal fistulae underwent clinical, FDA, PDAI, and AUS evaluation. Perianal disease was considered active in the presence of visible fistula drainage and/or signs of local inflammation (induration and pain at digital compression) upon clinical examination. The AUS images were analyzed by calculating the mean gray-scale tone of the lesion. The PDAI and gray-scale tone values discriminating active and inactive perianal disease were defined using receiver operating characteristics statistics.Results: Perianal disease was active in 46 patients. The accuracy of the FDA was 87% (confidence interval [CI]: 76%-94%). A PDAI of >4 and a mean gray-scale tone value of 117 maximized sensitivity and specificity; their diagnostic accuracy was, respectively, 87% (CI: 76%-94%) and 81% (CI: 69%-90%). The agreement of the 3 evaluations was fair to moderate. The addition of AUS to the PDAI or FDA increased their diagnostic accuracy to respectively 95% and 98%.Conclusions: The diagnostic accuracy of the FDA, PDAI, and computer-assisted AUS imaging was good in assessing perianal disease activity in patients with CD. The agreement between the techniques was fair to moderate. Overall accuracy can be increased by combining the FDA or PDAI with AUS.(Inflamm Bowel Dis 2008)
Case of linear IgA bullous dermatosis-involved ulcerative colitis
Tomonori Taniguchi, Hideki Maejima, Norimitsu Saito, Kensei Katsuoka, Satomi Haruki Thu, 20 Nov 2008 10:14:00 -0000
No abstract.
Predictive value of serologic markers in a population-based norwegian cohort with inflammatory bowel disease
Inger Camilla Solberg, Idar Lygren, Milada Cvancarova, Jørgen Jahnsen, Njaal Stray, Jostein Sauar, Stefan Schreiber, Bjørn Moum, Morten H. Vatn, IBSEN Study Group Thu, 13 Nov 2008 15:22:00 -0000
Background: Perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) are proposed to be specific markers for ulcerative colitis (UC) and Crohn's disease (CD). Their prevalence and relationship to disease phenotype and outcome in unselected cohorts of patients with inflammatory bowel disease (IBD), however, is largely unclear. We studied the prevalence of these serologic markers in a population-based IBD cohort 10 years after diagnosis, and examined whether their presence could be related to distinct subgroups and outcome of disease.Methods: Of 685 living IBD patients, 620 met for a 10-year follow-up, of whom 526 (UC, n = 357 and CD, n = 169) participated in this study.Results: Twenty-seven percent (n = 46) of CD patients were ASCA-positive and 31% (n = 109) of UC patients were pANCA-positive. Positive ASCA was more frequent in CD patients with stricturing (P = 0.003) or penetrating (P = 0.012) complications than in those with inflammatory behavior at diagnosis. Moreover, the presence of ASCA was associated with an at least twice higher risk of evolving more severe disease behavior during follow-up (P < 0.001). In UC, pANCA expression was related to female gender (P = 0.005) and the use of azathioprine (P < 0.001), and in CD, to colon-limited disease and age [ge]40 years at diagnosis (P = 0.009 and P = 0.001, respectively).Conclusions: The prevalence of ASCA in CD and pANCA in UC appears markedly lower than in referral-based populations. Even with the low prevalence, our study gives further support to the role of ASCA and pANCA as markers for distinct phenotype and outcome of disease.(Inflamm Bowel Dis 2008)

Subscribe to Images RSS feed